v3.22.2.2
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Treasury Stock [Member]
Noncontrolling Interest [Member]
Retained Earnings [Member]
Total
Beginning balance, value at Dec. 31, 2020 $ 26,835 $ 106,501,396 $ (2,157,226) $ (90,014,500) $ 14,356,505
Beginning balance, shares at Dec. 31, 2020 26,834,709          
Stock-based compensation 326,164 326,164
Restricted common stock grant $ 450 (450)
Restricted common stock grant, shares 450,000          
Restricted common stock forfeitures $ (8) 8
Restricted common stock forfeitures, shares (7,500)          
Issuance of common stock through registered direct offering at $3.095 per share and accompanying warrants (net of offering expenses and placement agent discount) $ 2,800 6,726,200 6,729,000
Issuance of common stock through registered direct offering at $3.095 per share and accompanying warrants (net of offering expenses and placement agent discount), shares 2,800,000          
Issuance of common stock through registered direct offering at $2.80 per share and accompanying warrants (net of offering expenses and placement agent discount) $ 3,250 6,614,350 6,617,600
Issuance of common stock through registered direct offering at $2.80 per share and accompanying warrants (net of offering expenses and placement agent discount), shares 3,250,000          
Exercise of pre-funded common stock purchase warrants at $3.095 per share $ 7,200 22,276,800 22,284,000
Exercise of pre-funded common stock purchase warrants at $3.095 per share, shares 7,200,000          
Exercise of pre-funded common stock purchase warrants at $2.80 per share $ 11,050 30,928,950 30,940,000
Exercise of pre-funded common stock purchase warrants at $2.80 per share, shares 11,050,000          
Issuance of pre-funded common stock purchase warrants in connection with the registered direct offerings (1,817,548) (1,817,548)
Issuance of common stock purchase warrants at exercise price of $3.25 per share in connection with the registered direct offerings (49,398,510) (49,398,510)
Net income (loss) 21,721,858 21,721,858
Ending balance, value at Mar. 31, 2021 $ 51,577 122,157,360 (2,157,226) (68,292,642) 51,759,069
Ending balance, shares at Mar. 31, 2021 51,577,209          
Beginning balance, value at Dec. 31, 2020 $ 26,835 106,501,396 (2,157,226) (90,014,500) 14,356,505
Beginning balance, shares at Dec. 31, 2020 26,834,709          
Net income (loss)           24,388,307
Ending balance, value at Sep. 30, 2021 $ 52,703 123,968,757 (2,157,226) (19,863) (65,606,330) 56,238,041
Ending balance, shares at Sep. 30, 2021 52,702,947          
Beginning balance, value at Mar. 31, 2021 $ 51,577 122,157,360 (2,157,226) (68,292,642) 51,759,069
Beginning balance, shares at Mar. 31, 2021 51,577,209          
Stock-based compensation 330,213 330,213
Net income (loss) (5,382,487) (5,382,487)
Ending balance, value at Jun. 30, 2021 $ 51,577 122,487,573 (2,157,226) (73,675,129) 46,706,795
Ending balance, shares at Jun. 30, 2021 51,577,209          
Stock-based compensation 491,950 491,950
Restricted common stock grant $ 406 (406)
Restricted common stock grant, shares 406,000          
Net income (loss) (19,863) 8,068,799 8,048,936
Issuance of common stock as consideration for acquisition $ 720 989,640 990,360
Issuance of common stock as consideration for acquisition, shares 719,738          
Ending balance, value at Sep. 30, 2021 $ 52,703 123,968,757 (2,157,226) (19,863) (65,606,330) 56,238,041
Ending balance, shares at Sep. 30, 2021 52,702,947          
Beginning balance, value at Dec. 31, 2021 $ 50,904 124,426,379 56,453 (68,670,497) 55,863,239
Beginning balance, shares at Dec. 31, 2021 50,904,391          
Stock-based compensation 394,749 394,749
Restricted common stock grant $ 715 (715)
Restricted common stock grant, shares 715,000          
Restricted common stock forfeitures $ (15) 15
Restricted common stock forfeitures, shares (15,000)          
Net income (loss) (98,094) (6,600,148) (6,698,242)
Repurchase and cancellation of common stock $ (1,876) (2,061,892) (2,063,768)
Repurchase and cancellation of common stock, shares (1,876,034)          
Distribution to noncontrolling interest in consolidated subsidiary (15,692) (15,692)
Ending balance, value at Mar. 31, 2022 $ 49,728 124,820,428 (57,333) (77,332,537) 47,480,286
Ending balance, shares at Mar. 31, 2022 49,728,357          
Beginning balance, value at Dec. 31, 2021 $ 50,904 124,426,379 56,453 (68,670,497) 55,863,239
Beginning balance, shares at Dec. 31, 2021 50,904,391          
Net income (loss)           (9,299,498)
Ending balance, value at Sep. 30, 2022 $ 53,903 129,943,238 309,397 (82,261,430) 48,045,108
Ending balance, shares at Sep. 30, 2022 53,903,405          
Beginning balance, value at Mar. 31, 2022 $ 49,728 124,820,428 (57,333) (77,332,537) 47,480,286
Beginning balance, shares at Mar. 31, 2022 49,728,357          
Stock-based compensation 381,602 381,602
Restricted common stock forfeitures $ (50) 50
Restricted common stock forfeitures, shares (50,000)          
Net income (loss) 383,326 (1,065,513) (682,187)
Repurchase and cancellation of common stock $ (1,850) (1,960,905) (1,962,755)
Repurchase and cancellation of common stock, shares (1,849,952)          
Ending balance, value at Jun. 30, 2022 $ 47,828 125,202,080 325,993 (80,358,955) 45,216,946
Ending balance, shares at Jun. 30, 2022 47,828,405          
Stock-based compensation 251,733 251,733
Net income (loss) (16,596) (1,902,475) (1,919,071)
Issuance of common stock through warrant exchange agreement $ 6,075 4,489,425 4,495,500
Issuance of common stock through warrant exchange agreement, shares 6,075,000          
Ending balance, value at Sep. 30, 2022 $ 53,903 $ 129,943,238 $ 309,397 $ (82,261,430) $ 48,045,108
Ending balance, shares at Sep. 30, 2022 53,903,405